Blog & News
5 Information You Need To Know About The Covid-19 Vaccine Planned To Be Released Soon
05.11.2020
So what awaits us when the vaccine arrives? Can we go back to our old lives? The answers to all these questions are in the rest of our article.
The protection rate of the Covid-19 vaccine, which is planned to be distributed from the end of 2020 and the first months of 2021, is expected to be at least 50%. Scientists believe that achieving protection rates of 70% -80% will be a huge success. If the vaccine provides at least 50% protection as expected, hospital occupancy rates are expected to decrease significantly. In case of a decrease, patients who have chronic diseases and disrupt their doctor's appointments for fear of getting Covid-19 will be able to go to the hospital more comfortably.
Astra Zeneca, one of the world's pharmaceutical giants, and Oxford University joined forces for vaccine studies. It is expected that the results of the human trials will be announced at the end of the year regarding the vaccine, which is now coming to an end. Whether the vaccine will work or not will be determined at the end of the year.
After the vaccine has proven to work, a decision phase awaits us. First of all, it will be determined who should be vaccinated. The vaccine will primarily be given to people at high risk. These will be determined by countries and a road map for vaccination will be drawn.
The answer is unfortunately no. Once the vaccine is proven to work, not everyone will be vaccinated. First of all, people at risk will be able to benefit from the vaccine. As the vaccination continues, people carrying the virus will continue to be around us. In short, we will not be able to leave our masks for a while.
Scientists follow a 3-step clinical process so that a vaccine they produce can be applied on humans with peace of mind. In this process, a limited number of volunteers are vaccinated in the first stage of trials. When successful results are obtained as a result of this vaccination, the second vaccination is performed on more than 100 volunteers. If a positive result is obtained in the second step, the vaccine trial continues on thousands of subjects. Studies can take months or even years, as the side effects of the vaccine are observed over a long period of time and more subjects are involved with each step.